Back Sheridan, C (14 April 2025) 'Not just obesity: GLP-1 receptor agonists advance on addiction', Nature Biotechnology , 43, 455-47.Back Sims, EK, Carr, ALJ, Oram, RA, et al (15 July 2022) '100 years of insulin: celebrating the past, present and future of diabetes therapy', Nature Medicine , 27/7, 1154-64
Inteins: natures gift to protein chemists
Ongoing Optimization: Regular lab monitoring and physician check-ins to keep your treatment optimized
Recognizing the urgent need for a better solution, Success by Sesame emergeda program designed to make weight loss treatments like compounded semaglutide more affordable, accessible, and personalized than ever before
The persistent inflammation associated with long COVID is another fatigue contributor
Changes in cardiometabolic risk measures The SURMOUNT-OSA statistical analysis plan prespecified assessment of changes in SBP and DBP, hsCRP, HDL-C, non-HDL-C, LDL-C, VLDL-C and fasting insulin